Evidence map›Paper›PMID 29213921›Full record

ReviewDementia & neuropsychologia

Prevalence of dementia in Colombian populations.

Efraín Amaya Vargas, Ángela Magnolia Ríos Gallardo, Guillermo González Manrrique, Lina M Murcia-Paredes, María Consuelo Angarita Riaño, Grupo DNEUROPSY

Abstract readReview
In one paragraph

Review in Dementia & neuropsychologia. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Efraín Amaya VargasNeurologist, Professor of Medicine Program and Member of the Group DNEUROPSY - Surcolombiana University.
Ángela Magnolia Ríos GallardoPsychologist, PhD Psychology Focusing on Cognitive Neuroscience. Teacher and Director of the Group DNEUROPSY - Surcolombiana University.
Guillermo González ManrriqueNeurologist. Health Specialist in Management. Head of the Area of Neurophysiology University Hospital in Neiva. Professor and Member of the Group DNEUROPSY - Surcolombiana University.
Lina M Murcia-ParedesPsychologist. Specialist in Health Psychology, Masters Student in Psychology. Member of Group DNEUROPSY - Surcolombiana University.
María Consuelo Angarita RiañoGeneral Medical. Specialist in Management of Health Organizations. Master's Student in Public Health. Area Leader for Public Health. Department of Health - Huila.
Grupo DNEUROPSY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the gradual increase in the life expectancy of the population due to scientific progress and public health at the service of society, the prevalence of dementia has been increasing at different rates worldwide. Currently, the prevalence rates range between 5% and 7% (6.4% in the U.S. and up to 8.5 % in Latin America) in subjects older than 60 years. The lowest prevalence rate (2.1%) has been reported from sub-Saharan Africa, probably due to selective mortality under 60 years of age. By contrast, a very high prevalence of dementia (23.6% dementia in individuals >60 years) was observed in the city of Neiva, Southern Colombia. We believe that this high rate could be explained by the presence of several risk factors such as very low schooling, low socio-economic strata, chronic diseases, the inclusion of geriatric homes among others, and additional unknown factors.

Indexed as

caregiversdementia - epidemiologyhealth-care services for older people - economyhealth prioritiesprevalenceprevalence of dementia in Neiva and Colombia

Identifiers

PMID29213921
PMCPMC5619179

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.